| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.3025 | 52 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.2532 | 28 |
| GSM780709 | Untreated after 4 days (C3_1) | 56.9555 | 62 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.7581 | 36 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.179 | 42 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.2779 | 42 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.1784 | 52 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.9617 | 56 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 51.4621 | 53 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.1817 | 52 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.9875 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 55.3983 | 60 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.6934 | 35 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.6994 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.9468 | 48 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.3684 | 46 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.5234 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.0374 | 52 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.3284 | 49 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.9426 | 54 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.5785 | 50 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.6634 | 59 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.1384 | 46 |